Global Avian Influenza Vaccines Market Insights, Forecast to 2025
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.
The global average price of Avian Influenza Vaccines is in the decreasing trend, from 20 K USD/K doses in 2011 to 19.8 USD/K doses in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Avian Influenza Vaccines includes H5 Avian Influenza Vaccines, H9 Avian Influenza Vaccines and other Avian Influenza Vaccines, and the proportion of H5 Avian Influenza Vaccines in 2015 is about 73%, and the proportion is in decreasing trend from 2011 to 2015.
Avian Influenza Vaccines is widely used in Chicken, Duck & Goose and Other birds. The most proportion of Avian Influenza Vaccines is used in chicken, and the production proportion in 2015 is about 77%.
China region is the largest supplier of Avian Influenza Vaccines, with a production market share nearly 49% in 2015. Asia (Ex. China) is the second largest supplier of Avian Influenza Vaccines, enjoying production market share nearly 23% in 2015.
China is the largest consumption place, with a consumption market share nearly 45% in 2015. Following China, Asia (Ex. China) is the second largest consumption place with the consumption market share of 26%.
Market competition is intense. Merial, QYH Biotech, DHN, HVRI, CEVA, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Avian Influenza Vaccines market is valued at 100 million US$ in 2018 and will reach 130 million US$ by the end of 2025, growing at a CAGR of 2.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Avian Influenza Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Avian Influenza Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Avian Influenza Vaccines in these regions.
This research report categorizes the global Avian Influenza Vaccines market by top players/brands, region, type and end user. This report also studies the global Avian Influenza Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merial
CEVA
Zoetis
Elanco (Lohmann )
Merck Animal Health
Avimex Animal Health
Market size by Product
Type H5
Type H9
Other
Market size by End User
Chicken
Duck & Goose
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Avian Influenza Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Avian Influenza Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Avian Influenza Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Avian Influenza Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Avian Influenza Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Dose). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Avian Influenza Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The global average price of Avian Influenza Vaccines is in the decreasing trend, from 20 K USD/K doses in 2011 to 19.8 USD/K doses in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Avian Influenza Vaccines includes H5 Avian Influenza Vaccines, H9 Avian Influenza Vaccines and other Avian Influenza Vaccines, and the proportion of H5 Avian Influenza Vaccines in 2015 is about 73%, and the proportion is in decreasing trend from 2011 to 2015.
Avian Influenza Vaccines is widely used in Chicken, Duck & Goose and Other birds. The most proportion of Avian Influenza Vaccines is used in chicken, and the production proportion in 2015 is about 77%.
China region is the largest supplier of Avian Influenza Vaccines, with a production market share nearly 49% in 2015. Asia (Ex. China) is the second largest supplier of Avian Influenza Vaccines, enjoying production market share nearly 23% in 2015.
China is the largest consumption place, with a consumption market share nearly 45% in 2015. Following China, Asia (Ex. China) is the second largest consumption place with the consumption market share of 26%.
Market competition is intense. Merial, QYH Biotech, DHN, HVRI, CEVA, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Avian Influenza Vaccines market is valued at 100 million US$ in 2018 and will reach 130 million US$ by the end of 2025, growing at a CAGR of 2.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Avian Influenza Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Avian Influenza Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Avian Influenza Vaccines in these regions.
This research report categorizes the global Avian Influenza Vaccines market by top players/brands, region, type and end user. This report also studies the global Avian Influenza Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merial
CEVA
Zoetis
Elanco (Lohmann )
Merck Animal Health
Avimex Animal Health
Market size by Product
Type H5
Type H9
Other
Market size by End User
Chicken
Duck & Goose
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Avian Influenza Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Avian Influenza Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Avian Influenza Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Avian Influenza Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Avian Influenza Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Dose). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Avian Influenza Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
